SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-24-000372
Filing Date
2024-04-15
Accepted
2024-04-15 17:29:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 arca13g-04152024.htm SC 13G 142372
  Complete submission text file 0001013594-24-000372.txt   144204
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51477 | Film No.: 24845610
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address ONE STAMFORD PLAZA 263 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address ONE STAMFORD PLAZA 263 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-880-1802
Allostery Investments LP (Filed by) CIK: 0001978599 (see all company filings)

IRS No.: 883328512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G